We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
AUM
$149M
AUM Growth
-$98.9M
Cap. Flow
-$63.4M
Cap. Flow %
-42.57%
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
SONX
Sonendo, Inc.
SONX
+$8.75M
2
DHR icon
Danaher
DHR
+$4.9M

Top Sells

Rank Stock Value
1
TWST icon
Twist Bioscience
TWST
+$28.4M
2
TECH icon
Bio-Techne
TECH
+$13.2M
3
CTKB icon
Cytek Biosciences
CTKB
+$10.8M
4
NTRA icon
Natera
NTRA
+$9.19M
5
GH icon
Guardant Health
GH
+$5.03M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRA icon
1
Natera
NTRA
$46.9B
$35.4M 23.79%
881,436
-223,145
-20% -$9.19M
GH icon
2
Guardant Health
GH
$21.9B
$23.6M 15.87%
868,445
-110,000
-11% -$5.03M
ADPT icon
3
Adaptive Biotechnologies
ADPT
$4.07B
$23.2M 15.55%
3,030,434
-570,000
-16% -$4.43M
AKYA
4
DELISTED
Akoya BioSciences
AKYA
$17.7M 11.88%
1,847,785
-257,000
-12% -$3.16M
MXCT icon
5
MaxCyte
MXCT
$143M
$17.6M 11.83%
3,225,000
CTKB icon
6
Cytek Biosciences
CTKB
$611M
$13.3M 8.92%
1,300,000
-800,000
-38% -$10.8M
SONX
7
DELISTED
Sonendo, Inc.
SONX
$13.1M 8.83%
+4,643,461
New +$8.75M
DHR icon
8
Danaher
DHR
$149B
$4.98M 3.34%
+21,150
New +$4.9M
TECH icon
9
Bio-Techne
TECH
$11.3B
-186,000
Closed -$13.2M
TWST icon
10
Twist Bioscience
TWST
$8.93B
-805,000
Closed -$28.4M
SLGC
11
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
-992,086
Closed -$2.88M

Similar funds

Blue Water Life Science Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Blue Water Life Science Advisors held 11 positions worth $149M, down 40% from $248M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blue Water Life Science Advisors withdrew a net $63.4M in Q4 2022, closing 3 positions and reducing 5 holdings. Its most notable exit was Twist Bioscience, an estimated $28.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Blue Water Life Science Advisors opened a new position in Sonendo, Inc. worth $13.1M.

  • Blue Water Life Science Advisors's largest Q4 2022 buy was Sonendo, Inc.: 4,643,461 shares worth $13.1M.
  • Blue Water Life Science Advisors's biggest Q4 2022 reduction was Cytek Biosciences, cutting an estimated $10.8M.
  • Blue Water Life Science Advisors fully exited Twist Bioscience in Q4 2022, selling an estimated $28.4M.
  • Blue Water Life Science Advisors's ten largest holdings make up 100% of its $149M portfolio in Q4 2022.
  • Blue Water Life Science Advisors opened 2 new positions and closed 3 in Q4 2022.
  • Blue Water Life Science Advisors's portfolio value fell 40% quarter-over-quarter to $149M.

Based on Blue Water Life Science Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.